Effects of Macronutrients on Hepatic Lipids, Plasma Triglycerides, and Insulin Sensitivity

NCT ID: NCT00523562

Last Updated: 2018-06-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

41 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-07-31

Study Completion Date

2009-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess how the macronutrient composition of the diet effects

* lipid and glucose metabolism
* intrahepatic lipids
* insulin sensitivity

in healthy lean subjects and in subjects with a high metabolic risk (ie overweight and offsprings of patients with type 2 diabetes mellitus).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study is aimed at assessing the effects of changes in total energy, sugars, lipids, and protein intake on intrahepatic lipids, plasma lipids, and hepatic and whole body insulin resistance in

* lean men and women with no family history of diabetes
* overweight men and women
* lean men with a family history of type 2 diabetes

Subjects are studied after a 6-day period of

* isocaloric diet with 100% calorie requirement, of which 55% carbohydrate, 15% protein, and 30% fat)
* the same isocaloric diet supplemented with 3g/kg body weight/day fructose
* hypercaloric high fat diet with 130% energy requirement, of which 55% carbohydrate, 15% protein, 60% fat
* hypercaloric high fat+protein diet with 145% energy requirement, of which 55% carbohydrate, 30% protein, 60% fat

Measurements performed after 6 days on each diet include

* intrahepatic and intramyocellular lipids (1H-MRS)
* hepatic and whole body insulin sensitivity (hyperinsulinemic-euglycemic clamp)
* body weight
* plasma concentrations of hormones and substrates
* gene expression profile in skeletal muscle (vastus lateralis) and adipose tissue (subcutaneous abdominal)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metabolic Syndrome X Liver Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

normal weight male high fructose diet

Effects of diet intervention " high fructose" in normal weight subjects

Group Type EXPERIMENTAL

diet intervention

Intervention Type OTHER

controlled hypercaloric high fructose, high fat, or high fat/high protein diet

offsprings of T2DM high fructose diet

Effect of diet intervention "high fructose" in healthy non-obese offsprings of patients with type 2 diabetes

Group Type EXPERIMENTAL

diet intervention

Intervention Type OTHER

controlled hypercaloric high fructose, high fat, or high fat/high protein diet

normal weight subjects high fat diet

effects of diet intervention "high fat" in healthy male subjects

Group Type EXPERIMENTAL

diet intervention

Intervention Type OTHER

controlled hypercaloric high fructose, high fat, or high fat/high protein diet

Normal weight high fat+protein diet

effect of diet intervention "high fat + protein" subjects in healthy male subjects

Group Type EXPERIMENTAL

diet intervention

Intervention Type OTHER

controlled hypercaloric high fructose, high fat, or high fat/high protein diet

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

diet intervention

controlled hypercaloric high fructose, high fat, or high fat/high protein diet

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Males and females
* Age 18-40
* Informed consent obtained
* Subgroup with overweight (body mass index \[BMI\] \> 25)
* Subgroup with family history of type 2 diabetes mellitus

Exclusion Criteria

* Smokers
* Alcohol intake \> 30g/day
* Drug abuse
* Diabetes mellitus
* Any concurrent medication
* Having a pacemaker
* History of orthopedic surgery
* History of metal foreign bodies
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Lausanne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Luc Tappy, MD

Professor Luc Tappy

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Luc Tappy, MD

Role: PRINCIPAL_INVESTIGATOR

University of Lausanne

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier Universitaire Vaudois

Lausanne, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

References

Explore related publications, articles, or registry entries linked to this study.

Bortolotti M, Kreis R, Debard C, Cariou B, Faeh D, Chetiveaux M, Ith M, Vermathen P, Stefanoni N, Le KA, Schneiter P, Krempf M, Vidal H, Boesch C, Tappy L. High protein intake reduces intrahepatocellular lipid deposition in humans. Am J Clin Nutr. 2009 Oct;90(4):1002-10. doi: 10.3945/ajcn.2008.27296. Epub 2009 Aug 26.

Reference Type DERIVED
PMID: 19710199 (View on PubMed)

Le KA, Ith M, Kreis R, Faeh D, Bortolotti M, Tran C, Boesch C, Tappy L. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am J Clin Nutr. 2009 Jun;89(6):1760-5. doi: 10.3945/ajcn.2008.27336. Epub 2009 Apr 29.

Reference Type DERIVED
PMID: 19403641 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

protocol 140/04/CE/FBM

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Precision Nutrition and Metabolic Function
NCT04131166 ACTIVE_NOT_RECRUITING NA
Insulin Resistance Study
NCT00614757 SUSPENDED NA
Lipids and Insulin Sensitivity
NCT01466816 COMPLETED NA